DOLUTEGRAVIR-BASED ART IS SUPERIOR TO
NNRTI/PI-BASED ART IN CHILDREN AND ADOLESCENTS
Anna Turkova, for the ODYSSEY/PENTA-20 Trial Team
MRC Clinical Trial Unit at UCL, London, UK
ODYSSEY is an international multi-centre randomised non- inferiority trial evaluating dolutegravir (DTG) + 2NRTIs versus standard-of-care (SOC) in children starting first- or second-line ART.
